Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Optimal application of stereotactic body radiotherapy and radiofrequency ablation treatment for different multifocal hepatocellular carcinoma lesions in patients with Barcelona Clinic Liver Cancer stage A4–B1: a pilot study

Fig. 1

Flowchart of the study population. In total, 39 and 16 lesions and patients were finally used for data analysis, respectively. One exclusion criterion (III) indicates that the patients all had small lesions (fewer than two lesions ≥1 cm) and failed to show pre-treatment enhancement on the arterial phase of CT or MRI examination. Abbreviations: HCC: hepatocellular carcinoma; RFA: radiofrequency ablation; SBRT: stereotactic body radiotherapy; BCLC:Barcelona Clinical Liver Cancer; mRECIST: modified Response Evaluation Criteria in Solid Tumors

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us